Xerox Holdings Corporation has issued a pro‑ratta warrant distribution that will allow holders of common stock, Series A preferred shares and 3.75% convertible senior notes to receive one warrant for every two shares or notes they own. The warrants will be distributed on February 11, 2026, with a record date of February 9, 2026, and can be exercised either in cash or by delivering specified Xerox debt securities. An early‑expiration clause activates if the stock price reaches the warrant exercise price for 20 trading days within any 30‑day period, accelerating deleveraging when the share price rises.
The company’s stated goal is to improve its debt‑to‑equity ratio and preserve liquidity for its “Reinvention” strategy, which targets $300 million in synergies and requires significant capital to sustain operations amid a shrinking print market. By converting debt into equity, Xerox can reduce leverage while giving shareholders an additional path to benefit from future upside.
Xerox’s balance sheet has been under pressure, with a debt‑to‑equity ratio that peaked at 741.8% in recent quarters. Revenue from its core print business has declined, and the company has pursued acquisitions such as Lexmark and ITsavvy to diversify its service offerings. The warrant distribution is therefore a strategic move to shore up capital and signal confidence in the company’s long‑term transformation.
Investors previously reacted negatively to a January 21 announcement of a potential $250 million securities offering, which caused a sharp drop in the stock. The current warrant distribution may be viewed similarly, as it introduces potential dilution; however, the ability to exercise warrants with debt provides a mechanism to reduce leverage without immediate cash outlay, which could temper concerns if the share price moves favorably.
CEO Steve Bandrowczak emphasized that the company remains committed to strengthening its balance sheet and optimizing its capital structure as part of the Reinvention plan. He noted that the warrant program is a deliberate step to convert excess debt into equity, thereby improving financial flexibility for future investments.
If all warrants were exercised, the exercise price of $8.00 per share would be attractive only if the share price rises well above the current level of about $2.10. The program therefore offers a potential upside for shareholders while simultaneously providing Xerox with a tool to reduce debt, but it also carries a dilution risk that investors will monitor closely.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.